IndraLab

Statements

Tetracycline inhibits NLRP3. 2 / 2

| 2

reach

"NLRP3 inflammasome inhibitors such as tranilast, tetracycline, resveratrol, nicardipine, erythropoietin and colchicine are under clinical trials for management of COVID-19 [16]."

35662743

➶

reach

"The broad-spectrum tetracycline antibiotic Minocycline also inhibits the NLRP3 inflammasome in several disease models by a mechanism that involves the dampening of ROS generation [XREF_BIBR - XREF_BIBR]."

27942750

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Tetracycline inhibits NLRP3. 2 / 2

INDRA sources:

Databases

Reading